BR0107881A - Uso de fsh tratamento de infertilidade - Google Patents

Uso de fsh tratamento de infertilidade

Info

Publication number
BR0107881A
BR0107881A BR0107881-0A BR0107881A BR0107881A BR 0107881 A BR0107881 A BR 0107881A BR 0107881 A BR0107881 A BR 0107881A BR 0107881 A BR0107881 A BR 0107881A
Authority
BR
Brazil
Prior art keywords
dose
fsh
days
range
infertility treatment
Prior art date
Application number
BR0107881-0A
Other languages
English (en)
Inventor
Ernest Loumaye
Louise Duerr-Meyers
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26072975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0107881(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP00302840A external-priority patent/EP1142582A1/en
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of BR0107881A publication Critical patent/BR0107881A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"USO DE FSH PARA TRATAMENTO DE INFERTILIDADE". A presente invenção refere-se ao uso de FSH e/ou um análogo biologicamente ativo deste na produção de um medicamento para o tratamento de infertilidade em mulheres. O medicamento é para administração em uma dose inicial na faixa de 100 a 600 UI seguido por uma segunda dose pelo menos 3 dias após a fase de estimulação. Em uma modalidade, o medicamento é para administração de uma dose na faixa de 300 a 600 UI em cada terceiro dia dos primeiros 6 dias da fase de estimulação. Em outra modalidade, a dose inicial é na faixa de 100 a 500 UI, com a segunda dose sendo administrada entre três e seis, preferivelmente quatro, dias após a dose inicial.
BR0107881-0A 2000-01-27 2001-01-09 Uso de fsh tratamento de infertilidade BR0107881A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00300591 2000-01-27
EP00302840A EP1142582A1 (en) 2000-04-04 2000-04-04 Use of FSH for treating infertility
PCT/GB2001/000065 WO2001054715A1 (en) 2000-01-27 2001-01-09 Use of fsh for treating infertility

Publications (1)

Publication Number Publication Date
BR0107881A true BR0107881A (pt) 2003-04-01

Family

ID=26072975

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0107881-0A BR0107881A (pt) 2000-01-27 2001-01-09 Uso de fsh tratamento de infertilidade

Country Status (29)

Country Link
US (1) US7291593B2 (pt)
EP (2) EP1442748A1 (pt)
JP (1) JP5170928B2 (pt)
KR (2) KR100871502B1 (pt)
CN (1) CN1418107A (pt)
AR (1) AR027287A1 (pt)
AT (1) ATE267608T1 (pt)
AU (1) AU783121B2 (pt)
BG (1) BG65915B1 (pt)
BR (1) BR0107881A (pt)
CA (1) CA2397680A1 (pt)
CZ (1) CZ302835B6 (pt)
DE (1) DE60103503T3 (pt)
DK (1) DK1250148T4 (pt)
EA (1) EA004924B1 (pt)
EE (1) EE05444B1 (pt)
ES (1) ES2217113T5 (pt)
HR (1) HRP20020630A2 (pt)
HU (1) HU230833B1 (pt)
IL (2) IL150837A0 (pt)
MX (1) MXPA02007233A (pt)
NO (1) NO324626B1 (pt)
PL (1) PL211113B1 (pt)
PT (1) PT1250148E (pt)
RS (1) RS50805B (pt)
SI (1) SI1250148T2 (pt)
SK (1) SK287717B6 (pt)
TR (1) TR200401810T4 (pt)
WO (1) WO2001054715A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005501919A (ja) * 2001-09-12 2005-01-20 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 制御下の過排卵刺激におけるｈＣＧ及びＬＨの使用
MEP39208A (en) * 2001-09-12 2011-02-10 Merck Serono Sa USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
AU2002324183B2 (en) * 2001-09-12 2007-10-25 Merck Serono Sa Use of hCG and LH in controlled ovarian hyperstimulation
UA88879C2 (en) * 2003-09-02 2009-12-10 Эплайд Рисерч Системз Эрс Холдинг Н.В. Fsh glycosylation mutant
US7481748B2 (en) * 2005-09-22 2009-01-27 Kurt Manufacturing Company, Inc. Locking mechanism for a bicycle trainer
EP2150271A1 (en) * 2007-05-11 2010-02-10 The Texas A & M Univsersity System Hormone normalization therapy and uses thereof
AR081755A1 (es) 2010-04-02 2012-10-17 Hanmi Holdings Co Ltd Formulacion de accion prolongada de la hormona estimuladora de los foliculos donde se usa un fragmento de inmunoglobulina, metodo de preparacion y metodo para tratar a un sujeto que sufre un trastorno reproductivo
WO2015089656A1 (en) * 2013-12-20 2015-06-25 Fertilify Inc. Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health
CN111050787A (zh) * 2017-09-01 2020-04-21 辉凌公司 用于受控的卵巢刺激的组合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725579A (en) * 1985-02-21 1988-02-16 Serono Laboratories, Inc. Method of in vitro fertilization by a unique combination of gonadotropins

Also Published As

Publication number Publication date
KR100871499B1 (ko) 2008-12-05
EP1250148B1 (en) 2004-05-26
ES2217113T3 (es) 2004-11-01
AU2532101A (en) 2001-08-07
ATE267608T1 (de) 2004-06-15
HUP0204324A2 (en) 2003-05-28
JP2003520823A (ja) 2003-07-08
BG106943A (bg) 2003-02-28
US20030158106A1 (en) 2003-08-21
US7291593B2 (en) 2007-11-06
EE200200415A (et) 2003-12-15
PL211113B1 (pl) 2012-04-30
NO324626B1 (no) 2007-11-26
KR20070087253A (ko) 2007-08-27
DE60103503D1 (de) 2004-07-01
KR20020081273A (ko) 2002-10-26
NO20023354L (no) 2002-09-24
EA004924B1 (ru) 2004-10-28
CZ302835B6 (cs) 2011-11-30
CA2397680A1 (en) 2001-08-02
CZ20022555A3 (cs) 2002-11-13
AR027287A1 (es) 2003-03-19
EP1250148A1 (en) 2002-10-23
IL150837A0 (en) 2003-02-12
SK287717B6 (en) 2011-07-06
PL356925A1 (en) 2004-07-12
WO2001054715A1 (en) 2001-08-02
HU230833B1 (hu) 2018-07-30
JP5170928B2 (ja) 2013-03-27
HUP0204324A3 (en) 2004-12-28
YU56702A (sh) 2005-09-19
CN1418107A (zh) 2003-05-14
EP1442748A1 (en) 2004-08-04
BG65915B1 (bg) 2010-05-31
PT1250148E (pt) 2004-09-30
MXPA02007233A (es) 2003-02-12
EA200200801A1 (ru) 2003-02-27
DE60103503T3 (de) 2008-12-24
KR100871502B1 (ko) 2008-12-05
RS50805B (sr) 2010-08-31
HRP20020630A2 (en) 2004-12-31
TR200401810T4 (tr) 2004-09-21
DE60103503T2 (de) 2005-06-09
EP1250148B2 (en) 2008-07-02
ES2217113T5 (es) 2008-11-01
SI1250148T2 (sl) 2008-10-31
SI1250148T1 (en) 2004-08-31
EE05444B1 (et) 2011-08-15
IL150837A (en) 2010-12-30
DK1250148T4 (da) 2008-09-22
DK1250148T3 (da) 2004-08-16
AU783121B2 (en) 2005-09-29
NO20023354D0 (no) 2002-07-11
SK10962002A3 (sk) 2002-12-03

Similar Documents

Publication Publication Date Title
KR960706344A (ko) 호르몬 피임 및/또는 여드름 치료 수단 및 방법(means and method for hormonal contraception and/or the treatment of acne)
BR9808888A (pt) Formas de dosagem e método de melhorar disfunção erétil masculina
ATE309798T1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
KR960700742A (ko) 아토피성질환 치료약(atopic disease remedy)
BR9709934A (pt) Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
MY107088A (en) Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof
BR9711642A (pt) Uso de uma combinação de amoxicilina e clavulanato na fabricação de medicamento para o tratamento de streptococcus pneumonia resistente a drogas
AR004510A1 (es) Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento
AU1935788A (en) A process for producing an administration and/or dosage form for medically active ingredients of drugs
Samra et al. Fentanyl anesthesia and human brain-stem auditory evoked potentials
GR1002847B (el) Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
BR0107881A (pt) Uso de fsh tratamento de infertilidade
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
BR0008076A (pt) 16-hidroxiestratrienos como estrogênios de efeito seletivo
ES2139842T3 (es) Uso de la melatonina para tratar a pacientes que sufren drogodependencia.
DE69812100D1 (de) Adenosin enthaltendes arzneimittel
MY107420A (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances.
BR0207866A (pt) Uso de flumazenil na preparação de um medicamento para o tratamento da dependência de cocaìna
AR002727A1 (es) El uso de ridogrel para la fabricacion de un medicamento util para el tratamiento de enfermedades digestivas inflamatorias, una composicionfarmaceutica que comprende ridogrel y un procedimiento para preparar dicha composicion.
NZ284914A (en) use of anti-arthritogenic peptide antibodies, nonadsorbable antibiotic or benign bacteria to treat rheumatoid arthritis by enteral administration
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
HUP9901935A2 (hu) Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: LABORATOIRES SERONO S.A. (CH)

Free format text: TRANSFERIDO DE: APPLIED RESEARCH SYSTEMS ARS HOLDING N.V.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 10 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B25E Requested change of name of applicant rejected

Owner name: LABORATOIRES SERONO S.A. (CH)